TAUNS Laboratories, Inc.
197A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥2,368,410 | ¥1,020,074 | ¥5,626,894 | ¥5,561,397 |
| % Growth | 132.2% | -81.9% | 1.2% | – |
| Cost of Goods Sold | ¥738,403 | ¥930,278 | ¥1,662,596 | ¥1,651,320 |
| Gross Profit | ¥1,630,007 | ¥89,796 | ¥3,964,298 | ¥3,910,077 |
| % Margin | 68.8% | 8.8% | 70.5% | 70.3% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥17,791 | ¥0 | ¥0 |
| SG&A Expenses | ¥1,082,484 | ¥1,155,496 | ¥1,172,050 | ¥1,116,804 |
| Sales & Mktg Exp. | ¥0 | ¥688,496 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥1,082,484 | ¥1,155,496 | ¥1,172,050 | ¥1,116,804 |
| Operating Income | ¥547,523 | -¥1,065,700 | ¥2,792,248 | ¥2,793,273 |
| % Margin | 23.1% | -104.5% | 49.6% | 50.2% |
| Other Income/Exp. Net | -¥41,336 | -¥30,242 | -¥21,027 | -¥21,967 |
| Pre-Tax Income | ¥506,187 | -¥1,095,942 | ¥2,771,221 | ¥2,771,306 |
| Tax Expense | ¥148,284 | -¥765,850 | ¥812,598 | ¥781,117 |
| Net Income | ¥357,902 | -¥330,092 | ¥1,958,624 | ¥1,990,189 |
| % Margin | 15.1% | -32.4% | 34.8% | 35.8% |
| EPS | 3.47 | -3.23 | 19.14 | 19.57 |
| % Growth | 207.4% | -116.9% | -2.2% | – |
| EPS Diluted | 3.33 | -3.05 | 17.94 | 18.55 |
| Weighted Avg Shares Out | 103,179 | 102,049 | 102,358 | 101,691 |
| Weighted Avg Shares Out Dil | 107,478 | 108,208 | 109,193 | 107,272 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥8,450 | ¥1,170 | ¥3,891 | ¥579 |
| Interest Expense | ¥50,750 | ¥38,109 | ¥31,280 | ¥17,736 |
| Depreciation & Amortization | ¥182,437 | ¥182,149 | ¥183,181 | ¥178,128 |
| EBITDA | ¥739,374 | -¥875,684 | ¥2,985,684 | ¥2,967,170 |
| % Margin | 31.2% | -85.8% | 53.1% | 53.4% |